Year: 2016
Type: article
Abstract: Metabolism is remodeled when somatic cells are reprogrammed into induced pluripotent stem cells (iPSCs), but the majority of iPSCs are not fully reprogrammed. In a shift essential for reprogramming, iPSCs use less mitochondrial respiration but increased anaerobic glycolysis for bioenergetics. We found that microRNA 31 (miR-31) suppressed succinate dehydrogenase complex subunit A (SDHA) expression, vital for mitochondrial electron transport chain (ETC) complex II. MiR-31 overexpression in partially reprogrammed iPSCs lowered SDHA expression levels and oxygen consumption rates to that of fully reprogrammed iPSCs, but did not increase the proportion of fully reprogrammed TRA1-60(+) cells in colonies unless miR-31 was co-transduced with Yamanaka factors, which resulted in a 2.7-fold increase in full reprogramming. Thus switching from mitochondrial respiration to glycolytic metabolism through regulation of the miR-31/SDHA axis is critical for lowering the reprogramming threshold. This is supportive of multi-stage reprogramming whereby metabolic remodeling is fundamental.
Source: Stem Cell Reports
Authors: Man Ryul Lee, Charlie Mantel, Sang A. Lee, Sung-Hwan Moon, Hal E. Broxmeyer
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,190
Funders: Ministry of Education, Ministry of Health and Welfare, Korea Health Industry Development Institute, National Research Foundation of Korea, National Institutes of Health, U.S. Public Health Service, National Heart, Lung, and Blood Institute, NIH Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Mechanisms of Synergistic Regulation of Stem/Progenitors, G1789368356, Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy, G3304014736, Cytokine Enhancement of Myeloid Progenitor Cell Survival, G5446093349, G5623536667, Enhancing Engraftment of Cord Blood by CD26 Inhibition, G8147031168, G8165701626, G8747243994, G8937506622, Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
OpenAlex ID: W2471967064
